What are clinical trials and why do we need them?

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> He knew he could stop if the side effects became too bad. He felt the staff explained it well, but not everyone wants as much information as he did.

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> Tom was invited to join a non-randomised Phase 2 trial of chemotherapy for inoperable lung cancer. He knew it might not help him, but might help other

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> Joining a trial when you have a serious illness is very different to ‘healthy volunteer’ trials. People need more information and education about tria

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> After he’d started the trial, there were scare stories about the type of treatment being tested. He felt it was too late to stop, but might have thoug

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> David joined a trial of treatments for asthma because he wanted to learn more about the condition, as well as to help medical research. The expenses p

Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> David had expected to feel like a guinea pig, but actually felt it had been interesting and worthwhile. He was pleased to have a personal debrief with

Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Julian - Interview 33 >> Julian joined a Phase 1 prostate cancer trial hoping it would benefit him, but also to help find out if the drug is safe for others. Phase 2 trials of

Julian has prostate cancer. He is in a Phase 1 trial of a drug (a PARP inhibitor) which may stop cancer cells regrowing in people like him who have the BRCA2 genetic mutation. This mutation increases the risk of prostate and other cancers.

Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> It was a relief when the trial ended and he no longer had to cope with side effects and lots of blood tests, but he also felt quite worried and unsure

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

Mail to a friend